Skip to main content

Table 3 Medication use among males & females with FXS

From: Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization

 

Total

Gender

Medication type

 

Female

Male

SSRI

27.8%

33.3%

24.1%

Anti-depressant

6.2%

2.6%

8.6%

Anti-psychotic

20.6%

15.4%

24.1%

Stimulant

24.7%

17.9%

29.3%

AED/Anti-convulsant

7.2%

.0%

12.1%

SNRI

4.1%

2.6%

5.2%

Miscellaneous

18.6%

15.4%

20.7%

Sedative

1.0%

.0%

1.7%

Anti-histamine

1.0%

.0%

1.7%

Anti-anxiety

1.0%

.0%

1.7%

No medications

46.4%

53.8%

41.4%

Total medications

1.2

.9

1.4